Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gem-TIP salvage chemotherapy for relapsed germ cell cancer
ISRCTN37453564Phase 2Completed
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine, paclitaxel, ifosfamide and cisplatin in germ cell tumor (GCT) and testicular cancer, sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Maximum tolerated dose. Started Oct 2005; status: completed.
02
Drugs
gemcitabinepaclitaxelifosfamidecisplatin
03
Conditions
germ cell tumor (GCT)testicular cancer
Beyond the preview
Go deeper on ISRCTN37453564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN37453564.